A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
Clinical trial NCT05337137 · COMPLETED
Trial details
- NCT number
- NCT05337137
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2025-07-05
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.